Long-term engraftment, graft-vs.-host disease, and immunologic reconstitution after experimental transplantation of allogeneic peripheral blood cells from G-CSF-treated donors

Biology of Blood and Marrow Transplantation

Volumn 2, Issue 3, 1996, Pages 126-133

  Pan, Luying ^b   Bressler, Scott ^b   Cooke, Kenneth R ^b   Krenger, Werner ^b   Karandikar, Mahesh ^b   Ferrara, James L M ^a  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b NONE

Author keywords

Engraftment; Graft vs. host disease; Granulocyte colony stimulating factor; Transplantation

Indexed keywords

CYTOKINE; GRANULOCYTE COLONY STIMULATING FACTOR;

ALLOTRANSPLANTATION; ANIMAL; ARTICLE; BIOSYNTHESIS; CYTOLOGY; DRUG EFFECT; FEMALE; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; IMMUNITY; IMMUNOLOGY; IMMUNOSUPPRESSIVE TREATMENT; MORTALITY; MOUSE; PHYSIOLOGY; SPLEEN; SURVIVAL RATE; T LYMPHOCYTE; TIME; TISSUE TRANSPLANTATION;

ANIMALS; CYTOKINES; FEMALE; GRAFT VS HOST DISEASE; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM CELL TRANSPLANTATION; IMMUNITY; MICE; SPLEEN; SURVIVAL RATE; T-LYMPHOCYTES; TIME FACTORS; TISSUE TRANSPLANTATION; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS;

EID: 0030252731     PISSN: 10838791     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Vogelsang GB, Hess AD: Graft-versus-host disease: new directions for a persistent problem. Blood 84:2061, 1994.
2. Korngold R, Sprent J: Lethal graft-versus-host disease after bone marrow transplantation across minor histocompatibility barriers in mice. Prevention by removing mature T-cells from marrow. J Exp Med 148:1687, 1978.
3. Pietryga DW, Blazar BR, Soderling CC, Vallera DA: The effect of T subset depletion on the incidence of lethal graft-versus-host disease in a murine major-histocompatibility-complex-mismatched transplantation system. Transplantation 43:442, 1987.
4. Soderling CC, Song CW, Blazar BR, Vallera DA: A correlation between conditioning and engraftment in recipients of MHC-mismatched T cell-depleted murine bone marrow transplants. J Immunol 135:941, 1985.
5. Gale RP: T cells, bone marrow transplantation and immunotherapy: use of monoclonal antibodies. Ann Intern Med 106:257, 1987.
6. Truitt RL, LeFever AV, Shih CCY, Jeske JM, Martin TM: Graft-vs.-leukemia effect. In: SJ Burakoff, HJ Deeg, J Ferrara, K Atkinson (eds) Graft-vs.-Host Disease: Immunology, Pathophysiology, and Treatment. New York: Marcel Dekker, 177, 1990.
7. Dreger P, Suttorp M, Haferlach T, Loffler H, Schmitz N: Allogeneic granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells for treatment of engraftment failure after bone marrow transplantation. Blood 81:1404, 1993.
8. Russell NH, Hunter A, Rogers S, Hanley J, Anderson D: Peripheral blood stem cells as an alternative to marrow for allogeneic transplantation. Lancet 341:1482, 1993.
9. Sasaki A, Tsukaguchi M, Hirai M, Ohira H, Nakao Y, Yamane T, Park K, Im T, Tatsumi N: Transplantation of allogeneic peripheral blood stem cells after myeloablative treatment of a patient in blastic crisis of chronic myelocytic leukemia. Am J Hematol 47:45, 1994.
10. Molina L, Chabannon C, Viret F, Moine A, Leger J, Nicolini F, Hollard D, Sotto J-J: Granulocyte colony-stimulating factor-mobilized allogeneic peripheral blood stem cells for rescue graft failure after allogeneic bone marrow transplantation in two patients with acute myeloblastic leukemia in first complete remission. Blood 85:1678, 1995.
11. Bensinger WI, Weaver CH, Appelbaum FR, Rowley S, Demirer T, Sanders J, Storb R, Buckner CD: Transplantation of allogeneic peripheral blood stem cells mobilized by recombinant human granulocyte colony-stimulating factor. Blood 85:1655, 1995.
12. Korbling M, Przepiorka D, Huh YO, Engel H, Van Besien K, Giralt S, Andersson B, Kleine HD, Seong D, Deisseroth AB, Andreeff M, Champlin R: Allogeneic blood stem cell transplantation for refractory leukemia and lymphoma: potential advantage of blood over marrow allograft. Blood 85:1659, 1995.
13. Schmitz N, Dreger P, Suttorp M, Rohwedder EB, Haferlach T, Loffler H, Hunter A, Russell NH: Primary transplantation of allogeneic peripheral blood progenitor cells mobilized by Filgrastim (granulocyte colony-stimulating factor). Blood 85:1666, 1995.
14. Russell JA, Luider J, Weaver M, Brown C, Selinger S, Railton C, Karlsson L, Klassen J: Collection of progenitor cells for allogeneic transplantation from peripheral blood of normal donors. Bone Marrow Transplant 15:111, 1995.
15. Martinez JA, Picon I, Carral A, de la Rubia J, Sanz G, Sanz MA: Allogeneic peripheral blood progenitor cells mobilized by G-CSF (filgrastim) for a second transplant in a patient with acute myeloid leukemia in relapse. Bone Marrow Transplant 15:149, 1995.
16. Tanaka J, Imamura M, Zhu X, Kobayashi S, Imai K, Hashino S, Sakurada K, Kasai M, Higa T: Potential benefit of recombinant human granulocyte colony-stimulating-mobilized peripheral blood stem cells for allogeneic transplantation. Blood 84:3595, 1994.
17. Bensinger WI, Clift RA, Anasetti C, Appelbaum FA, Demirer T, Rowley S, Sandmaier BM, Torok-Storb B, Storb R, Buckner CD: Transplantation of allogeneic peripheral blood stem cells mobilized by recombinant human granulocyte colony stimulating factor. Stem Cells 14:90, 1996.
18. Pan L, Delmonte J, Jalonen CK, Ferrara JLM: Pretreatment of donors with granulocyte colony-stimulating factor polarizes donor T lymphocytes toward type 2 cytokine production and reduces severity of experimental graft versus host disease. Blood 86:4422, 1995.
19. Mowat A: Antibodies to IFN-gamma prevent immunological mediated intestinal damage in murine graft-versus-host reactions. Immunol 68:18, 1989.
20. Nestel FP, Price KS, Seemayer TA, Lapp WS: Macrophage priming and lipopolysaccharide-triggered release of tumor necrosis factor alpha during graft-versus-host disease. J Exp Med 175:405, 1992.
21. Rus V, Svetic A, Nguyen P, Gause WC, Via CS: Kinetics of Th1 and Th2 cytokine production during the early course of acute and chronic murine graft-versus-host disease. J Immunol 155:2396, 1995.
22. Fowler DH, Kurasawa K, Smith R, Eckhaus MA, Gress RE: Donor CD4-enriched cells of Th2 cytokine phenotype regulate graft-versus-host disease without impairing allogeneic engraftment in sublethally irradiated mice. Blood 84:3540, 1994.
23. + donor T cells fail to induce experimental acute graft-versus-host disease. J Immunol 155:585, 1995.
24. DeWit D, Van Mechelen M, Zanin C, Doutrelepont J-M, Velu T, Gerard C, Abramowicz D, Scheerlinck J-P, De Baetselier P, Urbain J, Leo O, Goldman M, Moser M: Preferential activation of Th2 cells in chronic graft-versus-host disease. J Immunol 150:361, 1993.
25. Atkinson K, Horowitz MM, Gale RP, van Bekkum DW, Gluckman E, Good RA, Jacobsen N, Kolb HJ, Rimm AA, Ringden O, Rozman C, Sobocinski KA, Zwaan FE, Bonin MM: Risk factors for chronic graft-versus-host disease after HLA-identical sibling bone marrow transplantation. Blood 75:2459, 1990.
26. Goldman J: Peripheral blood stem cells for allografting. Blood 85:1413, 1995.
27. Morse HC III, Shen F-W, Hämmerling U: Genetic nomenclature for loci controlling mouse lymphocyte antigens. Immunogenetics 25:71, 1987.
28. Marshak-Rothstein A, Fink P, Gridley T, Raulet DH, Bevan MJ, Gefter ML: Properties and applications of monoclonal antibodies directed against determinants of the Thy-1 locus. J Immunol 122:2491, 1979.
29. Unkeless JC: Characterization of a monoclonal antibody directed against mouse macrophage and lymphocyte Fc receptors. J Exp Med 150:580, 1979.
30. Bungart B, Loeffler M, Goris H, Dontje B, Diehl V, Nijhof W: Differential effects of recombinant human colony stimulating factor (rh G-CSF) on stem cells in marrow, spleen and peripheral blood in mice. Br J Haematol 76:174, 1990.
31. Krenger W, Ferrara JLM: Graft-versus-host disease and the Th1/Th2 paradigm. Immunol Res 15:50, 1996.
32. Krenger W, Ferrara JLM: Dysregulation of cytokines during graft-versus-host disease. J Hematother 5:3, 1996.
33. Fowler DH, Kurasawa K, Husebekk A, Cohen PA, Gress RE: Cells of the Th2 cytokine phenotype prevent LPS-induced lethality during murine graft-versus-host reaction. J Immunol 152:1004, 1994.
34. Kitabayashi A, Hirokawa M, Hatano Y, Lee M, Kuroki J, Niitsu H, Miura AB: Granulocyte colony stimulating factor downregulates allogeneic immune response by posttranscriptional inhibition of tumor necrosis factor-α production. Blood 86:2220, 1995.
35. Hartung T, Docke WD, Grabtner F, Krieger G, Sauer A, Stevens P, Volk HD, Wendel A: Effect of granulocyte colony-stimulating factor treatment on ex vivo blood cytokine response in human volunteers. Blood 85:2482, 1995.
36. Cooke KR, Kobzik L, Martin TR, Brewer J, Delmonte J Jr, Crawford JM, Ferrara JLM: An experimental model of idiopathic pneumonia syndrome after bone marrow transplantation: The roles of minor H antigens and endotoxin. Blood 8:3230, 1996.
37. Atkinson K: Pathogenesis of human chronic graft-vs.-host disease. In: SJ Burakoff, HJ Deeg, J Ferrara, K Atkinson (eds) Graft-vs.-Host Disease: Immunology, Pathophysiology, and Treatment. New York: Marcel Dekker, 615, 1990.
38. Allen RD, Staley TA, Sidman CL: Differential cytokine expression in acute and chronic murine graft-versus-host disease. Eur J Immunol 23:333, 1993.
39. Umland SP, Razac S, Nahrebne DK, Seymour BW: Effects of in vivo administration of interferon (IFN)-gamma, anti-IFN-gamma, or anti-interleukin-4 monoclonal antibodies in chronic autoimmune graft-versus-host disease. Clin Immunol Immunopathol 63:66, 1992.
40. Goodman JW, Hodgson GS: Evidence for stem cells in the peripheral blood of mice. Blood 19:702, 1962.
41. McCredie KB, Hersh EM, Freireich EJ: Cells capable of colony formation in the peripheral blood of man. Science 171:293, 1971.
42. Bronchud MH: Recombinant human granulocyte colony-stimulating factor in the management of cancer patients: five years on. Oncology 51:189, 1994.
43. Tkatch LS, Tweardy DJ: Human granulocyte colony-stimulating factor (G-CSF), the premier granulopoietin: biology, clinical utility, and receptor structure and function. Lymphokine Cytokine Res 12:477, 1993.
44. Lane TA, Law P, Maruyama M, Young D, Burgess J, Mullen M, Mealiffe M, Terstappen LWMM, Hardwick A, Moubayed M, Oldham F, Corringham RET, Ho AD: Harvesting and enrichment of hematopoietic progenitor cells mobilized into the peripheral blood of normal donors by granulocyte-macrophage colony-stimulating factor (GM-CSF) or G-CSF: potential role in allogeneic marrow transplantation. Blood 85:275, 1995.
45. Bensinger WI, Longin K, Appelbaum F, Rowley S, Weaver C, Lilleby K, Gooley T, Lynch M, Higano T, Klarnet J, Chauncey T, Storb R, Buckner CD: Peripheral blood stem cells (PBSCs) collected after recombinant granulocyte colony stimulating factor (rhG-CSF): an analysis of factors correlating with the tempo of engraftment after transplantation. Br J Haematol 87:825, 1994.
46. Tanaka J, Kasai M, Imamura M, Asaka M: Clinical application of allogeneic peripheral blood stem cells transplantation. Ann Hematol 71:265, 1995.
47. Barrett, JA: Strategies to enhance the graft-versus-malignancy effect in allogeneic transplants. Ann NY Acad Sci 770:203, 1995.
48. Porter DL, Antin JH: Adoptive immunotherapy for relapsed leukemia following allogeneic bone marrow transplantation. Leuk Lymphoma 17:191, 1995.